Diamedica Therapeutics Inc (DMAC)
R&D Expense Growth
2.08%
Quarterly · Period ending:
DMAC R&D Expense Growth
Latest reported2.08%period ending
Latest reported2.08%period ending
DMAC Quarterly R&D Growth (QoQ) (0.00% → 2.08%)
Latest values, visible window
High-resolution chart · PNG
DMAC r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 2.0784% | |
| 19.2268% | |
| 4.0702% | |
| 10.5634% | |
| 2.9349% | |
| -12.5811% | |
| 29.8415% | |
| 26.8585% | |
| 6.8553% | |
| -0.0272% | |
| 12.3778% | |
| 28.6669% | |
| -29.7125% | |
| 59.3833% | |
| 38.4146% | |
| -16.1125% | |
| -0.9625% | |
| 5.5051% | |
| -19.7684% | |
| 8.1633% | |
| -10.3907% | |
| -22.8846% | |
| 44.5783% | |
| 34.875% | |
| 18.6064% | |
| -25.1387% | |
| 11.4409% | |
| -13.714% | |
| -28.1166% | |
| 8.267% | |
| 99.0031% | |
| 13.0841% | |
| 35.2718% | |
| 22.4015% | |
| 31.857% | |
| -46.3004% | |
| -21.1165% | |
| 173.1398% | |
| -42.8192% | |
| 101.1068% | |
| 53.7385% | |
| -9.1695% | |
| 80.0791% | |
| -27.8798% | |
| 130.5486% | |
| -79.0731% | |
| -42.3286% | |
| -22.718% | |
| -24.9876% | |
| 174.0019% | |
| -245.7861% | |
| -38.3185% | |
| 28.711% | |
| 272.5717% | |
| -137.2182% | |
| 13.7104% | |
| 173.0686% | |
| 145.5209% | |
| -218.5546% | |
| 2.9012% | |
| -7.2939% | |
| 386.2812% | |
| 78.1392% | |
| 19.3275% | |
| -32.3532% | |
| -35.6868% | |
| -17.8867% | |
| 128.8414% | |
| -57.8918% | |
| 279.4309% | |
| -140.1346% | |
| 21.585% | |
| 69.5599% | |
| 343.5247% | |
| -145.2042% | |
| -40.3725% | |
| 300.2181% | |
| -29.9606% | |
| -5.9611% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |